Streetbeat News

Price Targets

CLB

Stifel analyst Stephen Gengaro has maintained a Hold rating on Core Laboratories (NYSE:CLB) and reduced the price target from $23 to $21. The report was released on January 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:25 pm

CLB

Stifel analyst Stephen Gengaro has maintained a Hold rating on Core Laboratories (NYSE:CLB) but has reduced the price target from $23 to $21.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:25 pm

BFH

BMO Capital analyst James Fotheringham has maintained a Market Perform rating on Bread Finl Hldgs (NYSE:BFH) but has reduced the price target from $33 to $32.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:25 pm

HXL

BMO Capital analyst John McNulty has maintained a Market Perform rating on Hexcel (NYSE:HXL) and reduced the price target from $78 to $69.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:23 pm

NSC

BMO Capital analyst Fadi Chamoun has maintained a Market Perform rating on Norfolk Southern (NYSE:NSC) but has reduced the price target from $250 to $245.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:21 pm

BMI

Stifel analyst Nathan Jones has maintained a Hold rating on Badger Meter (NYSE:BMI) and increased the price target from $142 to $147, as reported on January 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:21 pm

AAL

AAPL

AMZN

BA

BMY

GOOGL

MSFT

SCHW

TSLA

Research suggests Bitcoin could reach $87K in this year's halving, while speculation on BTC ETFs could propel it to $500K. Tech giants Microsoft and Apple are leading earnings reports this week, potentially affecting market optimism. Charles Schwab may enter the Bitcoin ETF market. American Airlines and other stocks are set for varied market openings. Global politics and US-China tech tensions continue, with potential impacts on companies like Amazon, Alphabet, and Microsoft. Alibaba, Tencent, and TSMC are making strategic moves in China and Japan. Apple Card increases APY, and Tesla's Cybertruck tours China. Boeing faces challenges with the 737 Max, and Bristol Myers advances cancer treatment options.

Portfolio Pulse from Akanksha Bakshi

January 29, 2024 | 2:16 pm

FRME

Raymond James analyst Daniel Tamayo has maintained an Outperform rating on First Merchants (NASDAQ:FRME) and increased the price target from $33 to $40.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:08 pm

FMBH

Raymond James analyst Daniel Tamayo has maintained an Outperform rating on First Mid Bancshares (NASDAQ:FMBH) and increased the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:05 pm

LHX

Raymond James analyst Brian Gesuale has reaffirmed an Outperform rating on L3Harris Technologies (NYSE:LHX) and increased the price target from $220 to $235.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:04 pm